IRIS

Sfoglia per Rivista  CANCER RESEARCH

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 25 a 44 di 65
Titolo Data di pubblicazione Autore(i) File
Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice 1-gen-2006 Fedele, M; Fidanza, V; Battista, S; Pentimalli, F; KLEIN-SZANTO, Aj; Visone, R; DE MARTINO, I; Curcio, A; Morisco, C; DEL VECCHIO, L; Baldassarre, G; Arra, C; Croce, Cm; Fusco, A; Viglietto, G; Indolfi, C
Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 1-gen-2014 Iaccino, E; Mimmi, S; Falcone, C; Vecchio, E; Crescenzo, R; Maggisano, G; Carvelli, C; Russo, S; de Laurentiis, A; Pontoriero, M; Pisano, A; Ceglia, S; Fasanella Masci, F; Scialdone, A; Rossi, A; Fiume, G; Quinto, I; Scala, G.; Palmieri, C
HMGB1 and its isoform are sensitive and specific biomarkers to detect asbestos exposure and to identify mesothelioma patients 1-gen-2016 Napolitano, A; Antoine, Dj; Pellegrini, L; Baumann, F; Pagano, I; Pastorino, S; Goparaju, Cm; Prokrym, K; Canino, C; Pass, Hi; Carbone, M; Yang, Hn
Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins 1-gen-1996 Fedele, M; Bandiera, A; Chiappetta, G; Battista, S; Viglietto, G; Manfioletti, G; Casamassimi, A; Santoro, M; Giancotti, V; Fusco, A.
In vitro and in vivo activity of the maytansinoid immunoconjugate huN901-N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine against CD56+ multiple myeloma cells 1-gen-2004 Tassone, P; Gozzini, A; Goldmacher, V; Shammas, Ma; Whiteman, Kr; Carrasco, Dr; Li, C; Allam, Ck; Venuta, S; Anderson, Kc; Munshi, Nc.
In vitro and vivo activity against multiple myeloma cells of a novel locked nucleic acid (LNA)-miR-221 inhibitor 1-gen-2014 Di Martino, Mt; Gallo Cantafio, Me; Gulla, A; Altomare, E; Morelli, E; Amodio, N; Leone, E; Botta, C; Frandsen, Nm; Tagliaferri, P and Tassone P
Induction of ETS-1 and ETS-2 transcription factors is required for thyroid cell transformation 1-gen-2001 DE NIGRIS, F; Mega, T; Berger, N; Barone, Mv; Santoro, M; Viglietto, G; Verde, P; Fusco, A
Interleukin 6 receptor superantagonists are potent inducers of human multiple myeloma cell death 1-gen-1996 Demartis, A.; Bernassola, F.; Savino, R; Melino, G.; Ciliberto, G
Ligand-induced phosphorylation of a murine tumor surface protein (TSP-180) associated with metastatic phenotype 1-gen-1989 Sacchi, A; Falcioni, R; Piaggio, G; Gianfelice, Ma; Perrotti, N; Kennel, Sj
Microsatellite instability in gastric cancer is associated with tumor location and family history in a high-risk population from Tuscany 1-gen-1997 Ottini, L.; Palli, D.; Falchetti, M.; D'Amico, C.; Amorosi, A.; Saieva, C.; Calzolari, A.; Cimoli, F.; Tatarelli, C.; De Marchis, L.; Masala, G.; Mariani-Costantini, R.; Cama, A.
miR-579-3p is a novel master regulator of melanoma progression and drug resistance in metastatic melanoma 1-gen-2016 Fattore, L; Acunzo, M; Romano, G; Lagana, A; Malpicci, D; Pisanu, Me; Grimaldi, Am; Fulciniti, F; Croce, Cm; Mancini, R; Ascierto, Pa; Ciliberto, G
Mutations of the K-ras and p53 Genes in Gastric Adenocarcinomas from a High-Incidence Region around Florence, Italy 1-gen-1995 Hongyo, T.; Buzard, G. S.; Palli, D.; Weghorst, C. M.; Amorosi, A.; Galli, M.; Caporaso, N. E.; Fraumeni, J. F.; Rice, J. M.
MYC Mediates Large Oncosome-Induced Fibroblast Reprogramming in Prostate Cancer. 1-gen-2017 Minciacchi, Vr; Spinelli, C; Reis-Sobreiro, M; Cavallini, L; You, S; Zandian, M; Li, X; Mishra, R; Chiarugi, P; Adam, Rm; Posadas, Em; Viglietto, G; Freeman, Mr; Cocucci, E; Bhowmick, Na; Vizio, Dd.
Overexpression of proteins HMGA1 induces cell cycle deregulation and apoptosis in normal rat thyroid cells 1-gen-2001 Fedele, M; Pierantoni, Gm; Berlingieri, Mt; Battista, S; Baldassarre, G; Munshi, N; Dentice, M; Thanos, D; Santoro, M; Viglietto, G; Fusco, A.
Phosphoproteomic analysis of miR-21 modulation in Th17 cells: Potential implications for multiple myeloma bone disease therapy 1-gen-2018 Emanuela, Altomare; Rossi, Marco; Daniele, Caracciolo; Amodio, N; Gaspari, Marco; Domenico, Taverna; Scumaci, Domenica; Cirino, Botta; Annamaria, Gullà; Eugenio, Morelli; Paola, Critelli; Mariamena, Arbitrio; Pierosandro, Tagliaferri; Tassone, Pierfrancesco
Physical association with WWOX suppresses c-Jun transcriptional activity 1-gen-2006 Gaudio, E; Palamarchuk, A; Palumbo, T; Trapasso, F; Pekarsky, Y; Croce, Cm; Aqeilan, Ri
Preventive vaccination with telomerase controls tumor growth in genetically engineered and carcinogen-induced mouse models of cancer 1-gen-2008 Mennuni, C; Ugel, S; Mori, F; Cipriani, B; Iezzi, M; Pannellini, T; Lazzaro, D; Ciliberto, G; LA MONICA, N; Zanovello, P; Bronte, V; Scarselli, E
Progestins increase insulin receptor content and insulin stimulation of growth in human breast carcinoma cells 1-gen-1990 Papa, V; Reese, Cc; Brunetti, A; Vigneri, R; Siiteri, Pk; Goldfine, Id.
Promyelocytic leukemia protein is required for gain of function by mutant p53 1-gen-2009 Haupt, S.; Di Agostino, S.; Mizrahi, I.; Alsheich-Bartok, O.; Voorhoeve, M.; Damalas, A.; Blandino, G.; Haupt, Y.
Proteasomal degradation of topoisomerase I is preceded by c-Jun NH2-terminal kinase activation, Fas up-regulation, and poly(ADP-ribose) polymerase cleavage in SN38-mediated cytotoxicity against multiple myeloma 1-gen-2004 Catley, L; Tai, Yt; Shringarpure, R; Burger, R; Son, Mt; Podar, K; Tassone, P; Chauhan, D; Hideshima, T; Denis, L; Richardson, P; Munshi, Nc; Anderson, Kc.
Mostrati risultati da 25 a 44 di 65
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile